[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100574283":3},{"organization":4,"armGroups":7,"interventions":17,"overallOfficials":11,"centralContacts":11,"locations":22,"responsibleParty":34,"collaborators":11,"id":36,"slug":37,"hasResults":38,"nctId":39,"briefTitle":40,"officialTitle":40,"acronym":11,"eligibilityCriteria":41,"healthyVolunteers":38,"sex":42,"minAge":43,"maxAge":44,"enrollmentInfo":45,"targetDuration":11,"studyType":48,"phases":49,"briefSummary":51,"conditions":52,"keywords":11,"overallStatus":54,"whyStopped":11,"lastUpdateSubmitDate":55,"lastUpdatePostDateStruct":56,"startDateStruct":58,"completionDateStruct":60,"leadSponsor":62,"locationsCount":63},{"fullName":5,"class":6},"Ain Shams University","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Alovera experminted arm","EXPERIMENTAL",null,[13],"Other: Second arm: Using aleovera for Prevention and Treatment of Chemotherapy-Induced Oral Mucositis",{"label":15,"type":16,"description":11,"interventionNames":11},"second group","NO_INTERVENTION",[18],{"type":6,"name":19,"description":20,"armGroupLabels":21,"otherNames":11},"Second arm: Using aleovera for Prevention and Treatment of Chemotherapy-Induced Oral Mucositis","Second arm : aleovera 3 times daily after brushing teeth",[9],[23],{"facility":24,"status":11,"city":25,"state":11,"zip":11,"country":26,"countryCode":27,"cosmosGeoPoint":28,"geoPoint":33,"contacts":11},"Faculty of dentistry","Cairo","Egypt","EG",{"type":29,"coordinates":30},"Point",[31,32],31.24967,30.06263,{"lat":32,"lon":31},{"type":35,"investigatorFullName":11,"investigatorTitle":11,"investigatorAffiliation":11,"oldNameTitle":11,"oldOrganization":11},"SPONSOR","100574283","efficacy-of-aleo-vera-use-in-prevention-and-treatment-of-chemotherapy-induced-oral-mucositis-in-a-group-of-egyptian-children-with-acute-leukemia-100574283",false,"NCT06757270","Efficacy of Aleo Vera Use in Prevention and Treatment of Chemotherapy-Induced Oral Mucositis in a Group of Egyptian Children with Acute Leukemia","Inclusion criteria\n\n1. Patients suffering from Acute leukemia( Acute Lymphocytic Leukemia ).\n2. Patients scheduled for chemotherapy treatment.\n3. Patients who range from 3 to 13 years old.\n4. Patients with no history of any chemotherapy or radiotherapy. 5 -Both sexes Exclusion Criteria\n\n1-Patients scheduled for radiotherapy treatment . 2-Existence of any signs or symptoms of oral mucositis. 3-Unwilling to participation in the study 4- Patients with any other systemic diseases or other neoplasms.","ALL","3 Years","13 Years",{"count":46,"type":47},40,"ACTUAL","INTERVENTIONAL",[50],"NA","evaluatation the efficacy of Aleovera in prevention and treatment of chemotherapy-induced oral mucositis in children suffering from acute leukemia in terms of appearance and severity",[53],"Oral Mucositis","COMPLETED","2024-12-26",{"date":57,"type":47},"2025-01-03",{"date":59,"type":47},"2023-03-07",{"date":61,"type":47},"2024-03-07",{"name":5,"class":6},1]